Neuron-specific enolase and lung cancer


Karnak D., Beder S., KAYACAN O., İBİŞ E., Oflaz G.

AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, cilt.28, sa.6, ss.586-590, 2005 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 28 Sayı: 6
  • Basım Tarihi: 2005
  • Doi Numarası: 10.1097/01.coc.0000177915.51805.6e
  • Dergi Adı: AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.586-590
  • Anahtar Kelimeler: neuron-specific enolase, bronchoalveolar lavage fluid, lung cancer, tumor marker, SERUM TUMOR-MARKERS, BRONCHOALVEOLAR LAVAGE, PROGNOSTIC VALUE, CARCINOEMBRYONIC ANTIGEN, DISEASE EXTENT, NSE, THERAPY, CHEMOTHERAPY, CYFRA-21-1, CARCINOMA
  • Ankara Üniversitesi Adresli: Evet

Özet

Objective: Serum and bronchoalveolar lavage fluid (BALF) neuronspecific enolase (NSE) levels in lung cancer have been investigated widely; however, their diagnostic values have not yet been clarified. The authors investigated the diagnostic validity of NSE in BALF and serum in lung cancer. Materials and